| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
i
|
|
|
|
Award pages
|
|
ii-iv
|
|
|
|
Contents
|
|
vi
|
|
| Platinum Priorities |
| Review Article and Original Articles together with the Full Length Editorials |
| Education |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology
26 October 2011
Abstract: Background: Hospital rankings have become integral to the marketing strategies of many health care systems. Methodology used in compiling these lists appears highly flawed. Objective: To imp...
|
Alexander Kutikov,
Boris Rozenfeld,
Brian L. Egleston,
Mohit Sirohi,
Raymond W. Hwang,
Robert G. Uzzo
et al.
|
435-439
|
|
|
|
Impact Factor for Ranking Academic Urologic Institutions
21 November 2011
Although serious criticism surrounds the measurement of scientific activity of individuals or institutions by counting impact factors, it continues to enjoy great popularity in the scientific communit...
|
Manfred P. Wirth,
Michael Froehner
|
440-441
|
|
|
|
Reply from Authors re: Manfred P. Wirth, Michael Froehner. Impact Factor for Ranking Academic Urologic Institutions. Eur Urol 2012;61:440–1
08 December 2011
We appreciate the comments regarding our work describing the academic ranking score (ARS), an objective measure of thought leadership in urology . The effort was motivated by reviewing the annual rank...
|
Alexander Kutikov,
Robert G. Uzzo
|
441-442
|
|
| Prostate Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy
24 October 2011
Abstract: Context: Approximately 15–25% of men who undergo radical prostatectomy for localized prostate cancer (PCa) will experience recurrence of their cancer; men with poorly differentiated cancer, ...
|
Andrew J. Stephenson,
Michel Bolla,
Alberto Briganti,
Cesare Cozzarini,
Judd W. Moul,
Mack Roach III,
Hein van Poppel,
Anthony Zietman
et al.
|
443-451
|
|
|
|
Treat Now or Later: The Dilemma of Postoperative Radiotherapy
05 December 2011
The management of adverse pathology following radical prostatectomy (RP) is a difficult treatment dilemma. The debate centers on three treatment paradigms: additional systemic therapy, additional loca...
|
Adam S. Kibel
|
452-454
|
|
|
|
Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer
07 November 2011
Abstract: Background: Currently available predictive models fail to assist clinical decision making in prostate cancer (PCa) patients who are possible candidates for radical prostatectomy (RP). New bi...
|
Giorgio Guazzoni,
Massimo Lazzeri,
Luciano Nava,
Giovanni Lughezzani,
Alessandro Larcher,
Vincenzo Scattoni,
Giulio Maria Gadda,
Vittorio Bini,
Andrea Cestari,
Nicolò Maria Buffi,
Massimo Freschi,
Patrizio Rigatti,
Francesco Montorsi
et al.
|
455-466
|
|
|
|
PSA is Dead, Long Live PSA
05 December 2011
Prostate-specific antigen (PSA) has been called many things in recent years, few of them nice. Some of the words used to describe PSA include over, discredited, and lost. The chair of the US Preventiv...
|
Andrew J. Vickers,
Hans Lilja
|
467-468
|
|
|
|
Reply from Authors re: Andrew J. Vickers, Hans Lilja. PSA Is Dead, Long Live PSA. Eur Urol 2012;61:467–8
21 December 2011
We really appreciated the comments reported in the full-length editorial by Vickers and Lilja about our study on the predictive role of preoperative prostate-specific antigen (PSA) isoform p2PSA and ...
|
Giorgio Guazzoni,
Massimo Lazzeri,
Luciano Nava,
Giovanni Lughezzani,
Alessandro Larcher,
Vincenzo Scattoni,
Giulio Maria Gadda,
Vittorio Bini,
Andrea Cestari,
Nicolò Maria Buffi,
Massimo Freschi,
Patrizio Rigatti,
Francesco Montorsi
et al.
|
469-470
|
|
|
|
Evaluation of Multiple Risk–Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
09 November 2011
Abstract: Background: Although case-control studies have identified numerous single nucleotide polymorphisms (SNPs) associated with prostate cancer, the clinical role of these SNPs remains unclear. Ob...
|
Robert J. Klein,
Christer Hallden,
Amit Gupta,
Caroline J. Savage,
Anders Dahlin,
Anders Bjartell,
Jonas Manjer,
Peter T. Scardino,
David Ulmert,
Peter Wallström,
Andrew J. Vickers,
Hans Lilja
et al.
|
471-477
|
|
|
|
It Is Time to Move On
02 December 2011
Prostate-specific antigen (PSA) screening is currently under scrutiny by many governmental agencies worldwide. Current practice for prostate cancer diagnosis relies on PSA-triggered biopsies that do n...
|
George N. Thalmann
|
478-479
|
|
|
|
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
07 November 2011
Abstract: Background: Few predictive models aimed at predicting the presence of lymph node invasion (LNI) in patients with prostate cancer (PCa) treated with extended pelvic lymph node dissection (ePL...
|
Alberto Briganti,
Alessandro Larcher,
Firas Abdollah,
Umberto Capitanio,
Andrea Gallina,
Nazareno Suardi,
Marco Bianchi,
Maxine Sun,
Massimo Freschi,
Andrea Salonia,
Pierre I. Karakiewicz,
Patrizio Rigatti,
Francesco Montorsi
et al.
|
480-487
|
|
|
|
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymphadenectomy: Optimizing a Risk-Adapted Surgical Approach
28 November 2011
The current manuscript by Briganti et al. updates a nomogram to predict the presence of lymph node metastases (LNM) in 588 patients who underwent retropubic radical prostatectomy (RPE) and an extende...
|
Axel Heidenreich
|
488-490
|
|
| Bladder Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Long-term Renal Function After Urinary Diversion by Ileal Conduit or Orthotopic Ileal Bladder Substitution
19 September 2011
Abstract: Background: Data on long-term renal function are scarce for ileal conduit diversion (ICD) and even rarer for orthotopic ileal bladder substitution (BS). Objective: Explore the changes in ren...
|
Xiao-Dong Jin,
Simone Roethlisberger,
Fiona C. Burkhard,
Frédéric Birkhaeuser,
Harriet C. Thoeny,
Urs E. Studer
et al.
|
491-497
|
|
|
|
Variables Affecting Long-term Maintenance of Renal Function Following Ileal Based Urinary Diversion
15 December 2011
Urinary diversion is performed most frequently at the time of radical cystectomy for bladder cancer but may also be required in a variety of benign urologic conditions. Some of the key principles of u...
|
Ja Hyeon Ku,
Seth P. Lerner
|
498-500
|
|
|
|
Reply from Authors re: Ja Hyeon Ku, Seth P. Lerner. Variables Affecting Long-term Maintenance of Renal Function Following Ileal Based Urinary Diversion. Eur Urol 2012;61:498–500
30 December 2011
We read with great interest the editorial written by Ku and Lerner on our paper, “Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution” . The foll...
|
Urs E. Studer
|
500-502
|
|
|
|
Should Follow-up Cystoscopy in Bacillus Calmette-Guérin–Treated Patients Continue After Five Tumour-Free Years?
17 November 2011
Abstract: Background: It is not known how long follow-up cystoscopy in tumour-free bacillus Calmette-Guérin (BCG)–treated patients should continue. Objective: Determine the incidence of late recurrenc...
|
Sten Holmäng,
Viveka Ströck
|
503-507
|
|
|
|
A Plea for Long-Term Surveillance in Bacillus Calmette-Guérin–Treated Non–Muscle-Invasive Bladder Cancer
08 December 2011
Guidelines provide detailed information on diagnosis and treatment but are less specific on how and how often patients need to be seen for follow-up after treatment for non–muscle-invasive bladder can...
|
Richard P. Meijer,
Bas W.G. van Rhijn
|
508-509
|
|
| Urothelial Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Laparoendoscopic Single-Site Upper Urinary Tract Surgery: Assessment of Postoperative Complications and Analysis of Risk Factors
22 August 2011
Abstract: Background: Laparoendoscopic single-site surgery (LESS) has been developed in an attempt to minimise the morbidity and scarring associated with surgical intervention. Objective: To evaluate ...
|
Francesco Greco,
Luca Cindolo,
Riccardo Autorino,
Salvatore Micali,
Robert J. Stein,
Giampaolo Bianchi,
Caterina Fanizza,
Luigi Schips,
Paolo Fornara,
Jihad Kaouk
et al.
|
510-516
|
|
|
|
Laparoendoscopic Single-Site Surgery for the Upper Urinary Tract: Awaiting Evidence
21 November 2011
Changes in surgical techniques, purported advances in particular, have traditionally been poorly studied and nearly always reported as a retrospective experience, looking back over a series of cases i...
|
Jonathan A. Coleman
|
517-518
|
|
|
|
Reply from Authors re: Jonathan A. Coleman. Laparoendoscopic Single-Site Surgery for the Upper Urinary Tract: Awaiting Evidence. Eur Urol 2012;61:517–8
08 December 2011
Minimally invasive surgery aims to provide effective treatment of diseases while decreasing access-related morbidity with reduced postoperative pain, shorter hospital stay, faster recovery, improved c...
|
Francesco Greco,
Luca Cindolo,
Riccardo Autorino
|
518-519
|
|
| Incontinence |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study
26 October 2011
Abstract: Background: In the treatment of patients with idiopathic overactive bladder (iOAB), high doses of botulinum toxin type A (BoNTA) were often associated with complications resulting from high ...
|
Pierre Denys,
Loïc Le Normand,
Idir Ghout,
Pierre Costa,
Emmanuel Chartier-Kastler,
Philippe Grise,
Jean-François Hermieu,
Gérard Amarenco,
Gilles Karsenty,
Christian Saussine,
Frédéric Barbot,
for the VESITOX study group in France
et al.
|
520-529
|
|
|
|
Finding the Correct Starting Dose for OnabotulinumtoxinA
15 December 2011
The article by Denys and colleagues in this edition of the journal reports the results of a multicentre double-blind randomised placebo-controlled dose-ranging study using onabotulinumtoxinA (ObTA) (B...
|
Christopher R. Chapple
|
530-532
|
|
|
|
Reply from Authors re: Christopher R. Chapple. Finding the Correct Starting Dose for OnabotulinumtoxinA. Eur Urol 2012;61:530–2
22 December 2011
The editorial comment submitted by Chapple is of great value, and we thank him for this. OnabotulinumtoxinA (ObTA) seems destined to become one of the new treatments for non-neurogenic (idiopathic) r...
|
Pierre Denys,
Emmanuel Chartier-Kastler
|
532-533
|
|
| Editorial |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Future of Urology
14 November 2011
Take Home Message: The focus in urology for the next decade will be on improved education and training to ensure that every patient receives high-quality urologic care that is delivered in an efficien...
|
Paul Abrams,
Maurizio Brausi,
Stefan Buntrock,
Thomas Ebert,
Hashim Hashim,
Hans-Göran Tiselius,
Jean-Jacques Wyndaele
et al.
|
534-540
|
|
| Reviews |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Systematic Review of Methods for Reporting Combined Outcomes After Radical Prostatectomy and Proposal of a Novel System: The Survival, Continence, and Potency (SCP) Classification
05 December 2011
Abstract: Context: Although oncologic results remain the main outcome assessment for radical prostatectomy (RP), there is a need to include both urinary continence and potency recovery in the assessme...
|
Vincenzo Ficarra,
Prasanna Sooriakumaran,
Giacomo Novara,
Oscar Schatloff,
Alberto Briganti,
Henk Van der Poel,
Francesco Montorsi,
Vip Patel,
Ashutosh Tewari,
Alexander Mottrie
et al.
|
541-548
|
|
|
|
Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
14 November 2011
Abstract: Context: We have recently witnessed a rapid increase in the number of effective systemic agents for men with metastatic castration-resistant prostate cancer (CRPC), including novel hormonal ...
|
Andrew J. Armstrong,
Mario A. Eisenberger,
Susan Halabi,
Stephane Oudard,
David M. Nanus,
Daniel P. Petrylak,
A. Oliver Sartor,
Howard I. Scher
et al.
|
549-559
|
|
|
|
The Correlation Between Metabolic Syndrome and Prostatic Diseases
17 November 2011
Abstract: Context: Metabolic syndrome (MetS), a cluster of several metabolic abnormalities with a high socioeconomic cost, is considered a worldwide epidemic. Recent epidemiologic and clinical data su...
|
Cosimo De Nunzio,
William Aronson,
Stephen J. Freedland,
Edward Giovannucci,
J. Kellogg Parsons
et al.
|
560-570
|
|
| Surgery in Motion |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Role of the Prostatic Vasculature as a Landmark for Nerve Sparing During Robot-Assisted Radical Prostatectomy
03 January 2012
Abstract: Background: Macroscopic landmarks are lacking to identify the cavernosal nerves (CNs) during radical prostatectomy. The prostatic and capsular arteries run along the lateral border of the pr...
|
Vipul R. Patel,
Oscar Schatloff,
Sanket Chauhan,
Ananthakrishnan Sivaraman,
Rair Valero,
Rafael F. Coelho,
Bernardo Rocco,
Kenneth J. Palmer,
Darian Kameh
et al.
|
571-576
|
|
| Prostate Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
17 November 2011
Abstract: Background: The European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculators (RCs) are validated tools for prostate cancer (PCa) risk assessment and include prostate v...
|
Monique J. Roobol,
Heidi A. van Vugt,
Stacy Loeb,
Xiaoye Zhu,
Meelan Bul,
Chris H. Bangma,
Arno G.L.J.H. van Leenders,
Ewout W. Steyerberg,
Fritz H. Schröder
et al.
|
577-583
|
|
|
|
Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer
05 December 2011
Abstract: Background: The current role of radical prostatectomy (RP) in patients with high-risk disease remains controversial. Objective: To identify which high-risk prostate cancer (PCa) patients mig...
|
Alberto Briganti,
Steven Joniau,
Paolo Gontero,
Firas Abdollah,
Niccolò M. Passoni,
Bertrand Tombal,
Giansilvio Marchioro,
Burkhard Kneitz,
Jochen Walz,
Detlef Frohneberg,
Chris H. Bangma,
Markus Graefen,
Alessandro Tizzani,
Bruno Frea,
R. Jeffrey Karnes,
Francesco Montorsi,
Hein Van Poppel,
Martin Spahn
et al.
|
584-592
|
|
| Kidney Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Comparison of Open and Minimally Invasive Partial Nephrectomy for Renal Tumors 4–7 Centimeters
05 December 2011
Abstract: Background: Indications for partial nephrectomy (PN) in the treatment of renal cell carcinoma are evolving, particularly for larger, more complex tumors. Objective: Compare single-institutio...
|
Preston C. Sprenkle,
Nicholas Power,
Tarek Ghoneim,
Karim A. Touijer,
Guido Dalbagni,
Paul Russo,
Jonathan A. Coleman
et al.
|
593-599
|
|
| Benign Prostatic Hyperplasia |
| |
Article Title |
Author(s) |
Pages |
|
|
|
180-W XPS GreenLight Laser Therapy for Benign Prostate Hyperplasia: Early Safety, Efficacy, and Perioperative Outcome After 201 Procedures
05 December 2011
Abstract: Background: Photoselective vaporisation of the prostate has evolved from the GreenLight 80-W KTP powered laser to the latest 180-W XPS laser involving a MoXy fibre. Objective: Evaluate the p...
|
Alexander Bachmann,
Gordon H. Muir,
Edward J. Collins,
Benjamin B. Choi,
Shahin Tabatabaei,
Oliver M. Reich,
Fernando Gómez-Sancha,
Henry H. Woo
et al.
|
600-607
|
|
| Incontinence |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center Prospective Study
14 November 2011
Abstract: Background: Transobturator slings are currently promoted for the treatment of stress urinary incontinence (SUI) after radical prostatectomy (RP), but data on outcome remain limited. Objectiv...
|
Julie Leruth,
David Waltregny,
Jean de Leval
|
608-615
|
|
| Case Study of the Month |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Diffusion-Weighted Magnetic Resonance Imaging Detects Local Recurrence After Radical Prostatectomy: Initial Experience
28 November 2011
Abstract: Current conventional cross-sectional imaging techniques, such as contrast-enhanced computed tomography and magnetic resonance imaging (MRI), are largely inaccurate in detecting local recurre...
|
Gianluca Giannarini,
Daniel P. Nguyen,
George N. Thalmann,
Harriet C. Thoeny
|
616-620
|
|
| Words of Wisdom |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Re: Stepwise Approach for Nerve Sparing Without Countertraction During Robot-Assisted Radical Prostatectomy: Technique and Outcomes
Kowalczyk KJ, Huang AC, Hevelone ND, et alEur Urol 2011;60:536–47Experts’ summary:These authors present the short- and intermediate-term outcomes on erectile function for reduction of assistant interv...
|
Jens-Uwe Stolzenburg,
Hasan Qazi
|
621
|
|
|
|
Re: Prediction of Erectile Function Following Treatment for Prostate Cancer
Alemozaffar M, Regan MM, Cooperberg MR, et al.JAMA 2011;306:1205–14Expert's summary:The authors conducted a prospective analysis of 1027 patients from nine US university-affiliated hospitals to assess...
|
Paul Schellhammer
|
622
|
|
|
|
Re: Role of Magnetic Resonance Imaging Before Initial Biopsy: Comparison of Magnetic Resonance Imaging–Targeted and Systematic Biopsy for Significant Prostate Cancer Detection
Haffner J, Lemaitre L, Puech P, et alBJU Int 2011;108:E171–8.Experts’ summary:The authors compared magnetic resonance imaging (MRI)–targeted biopsies with extended systematic biopsies for the detectio...
|
Nicolas Barry Delongchamps,
Marc Zerbib
|
622-623
|
|
|
|
Re: A Prospective, Randomized Pilot Study Evaluating the Effects of Metformin and Lifestyle Intervention on Patients With Prostate Cancer Receiving Androgen Deprivation Therapy
Nobes JB, Langley SE, Klopper T, Russell-Jones D, Laing RWBJU Int. In press. doi:10.1111/j.1464-410X.2011.10555.xExpert's summary:This randomized 6-mo interventional versus standard-of-care (controls)...
|
Mark A. Moyad
|
623-624
|
|
|
|
Re: Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the Reduction by Dutasteride of Prostate Cancer Events Trial
Roehrborn CG, Nickel JC, Andriole GL, et alUrology 2011;78:641–7Expert's summary:The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial, an international multicenter randomized, double-...
|
Matthias Oelke
|
624-625
|
|
|
|
Re: Postfertilization Autophagy of The Sperm Organelles Prevents Paternal Mitochondrial DNA Transmission
Al Rawi S, Louvet-Vallee S, Djeddi A, Sachse M, Culetto E, Hajjar C, Boyd L, Legouis R, Galy VScience 2011;334:1144–7Experts’ summary:The purpose of this work was to describe the relation between auto...
|
B. José Manuel Mayorga-Torres,
Walter Cardona-Maya
|
625-626
|
|
| Letters to the Editor NOT referring to a recent journal article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Aquaporin 3 Protein Expression in Transitional Cell Carcinoma: A Potential Marker With Regard to Tumour Progression and Prognosis?
22 December 2011
The mechanism by which water passes across biological membranes was a matter of debate until the discovery and elucidation of the aquaporin (AQP) water channels by Peter Agre and associates in the 199...
|
Peter C. Rubenwolf,
Stefan Denzinger,
Wolfgang Otto
|
627-628
|
|
|
|
iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience
22 December 2011
Preliminary experience exists with computer-assisted surgery (CAS) for laparoscopic procedures of the prostate and the kidney . Based on algorithms developed for inside-out tracking via the laparoscop...
|
Jens J. Rassweiler,
Michael Müller,
Markus Fangerau,
Jan Klein,
Ali S. Goezen,
Philippe Pereira,
Hans-Peter Meinzer,
Dogu Teber
et al.
|
628-631
|
|
| Letters to the Editor published online |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Re: Sven van den Bosch, J. Alfred Witjes. Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review. Eur Urol 2011;60:493–500
26 December 2011
We commend an excellent piece of work that was done by van den Bosch and Witjes on a really complex issue of long-term management of high-risk, non–muscle-invasive bladder cancer (HRNMIBC; G3pT1 blad...
|
Srijit Banerjee,
Vivekanandan Kumar
|
e13
|
|
|
|
Re: Tim O’Brien, Eleanor Ray, Rajinder Singh, Bola Coker, Ralph Beard, British Association of Urological Surgeons Section of Oncology. Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial). Eur Urol 2011;60:703–10
05 December 2011
We read with interest this paper on prevention of bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinoma (UUTUC) by using single intravesical dose of mitomycin C ...
|
Apul Goel,
Sagorika Paul
|
e14
|
|
|
|
Reply to Apul Goel and Sagorika Paul's Letter to the Editor re: Tim O’Brien, Eleanor Ray, Rajinder Singh, Bola Coker, Ralph Beard, British Association of Urological Surgeons Section of Oncology. Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial). Eur Urol 2011;60:703–10
05 December 2011
The authors’ suggestion of preoperative intravesical mitomycin C (MMC) is interesting but purely speculative. There is not a shred of evidence to support its use in this way. Let's get single-dose pos...
|
Tim O’Brien
|
e15
|
|
|
|
Re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer. Eur Urol 2011;60:776–83
12 December 2011
We were interested to read Roscigno et al's retrospective analysis of the role of extended lymph node dissection in upper tract urothelial cancer (UTUC) and the improved pathologic staging perhaps be...
|
Alison J. Birtle,
Rebecca Lewis,
Emma Hall,
on Behalf of the POUT Trial Management Group
|
e16
|
|
|
|
Reply to Alison J. Birtle, Rebecca Lewis, Emma Hall's Letter to the Editor on Behalf of the POUT Trial Management Group re: Marco Roscigno, Maurizio Brausi, Axel Heidenreich, et al. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer. Eur Urol 2011;60:776–83
12 December 2011
In our review article, we aimed to stress the prognostic and staging roles of an accurate lymph node dissection (LND) in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial...
|
Marco Roscigno
|
e17
|
|
|
|
Re: Henk G. van der Poel, Tessa Buckle, Oscar R. Brouwer, Renato A. Valdés Olmos, Fijs W.B. van Leeuwen. Intraoperative Laparoscopic Fluorescence Guidance to the Sentinel Lymph Node in Prostate Cancer Patients: Clinical Proof of Concept of an Integrated Functional Imaging Approach Using a Multimodal Tracer. Eur Urol 2011;60:826–33
15 December 2011
We have recently read the work of van der Poel et al. with great interest and would like to congratulate them for it is a very important step forward in near-infrared (NIR) fluorescence navigation su...
|
Karol Polom,
Dawid Murawa,
Wojciech Polom
|
e18
|
|
|
|
Reply to Karol Polom, Dawid Murawa, Wojciech Polom's Letter to the Editor re: Henk G. van der Poel, Tessa Buckle, Oscar R. Brouwer, Renato A. Valdés Olmos, Fijs W.B. van Leeuwen. Intraoperative Laparoscopic Fluorescence Guidance to the Sentinel Lymph Node in Prostate Cancer Patients: Clinical Proof of Concept of an Integrated Functional Imaging Approach Using a Multimodal Tracer. Eur Urol 2011;60:826–33
15 December 2011
Thank you for giving us the opportunity to respond to the letter of Polom et al concerning our manuscript . First, we would like to thank the authors for their congratulations and for acknowledging th...
|
Henk G. van der Poel,
Oscar R. Brouwer,
Nynke S. van den Berg,
Tessa Buckle,
Fijs W.B. van Leeuwen
et al.
|
e19-e20
|
|
|
|
Re: Gianluca Giannarini, Thomas M. Kessler, Frédéric D. Birkhäuser, George N. Thalmann, Urs E. Studer. Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit? Eur Urol 2011;60:955–60
15 December 2011
With great interest, we read the article by Giannarini et al. regarding the efficacy of antegrade bacillus Calmette- Guérin (BCG) perfusion for patients with non–muscle-invasive urothelial carcinoma ...
|
Shiu-Dong Chung,
Jeff Shih-Chieh Chueh,
Chao-Yuan Huang,
Hong-Jeng Yu
|
e21
|
|
|
|
Reply to Shiu-Dong Chung, Jeff Shih-Chieh Chueh, Chao-Yuan Huang, Hong-Jeng Yu's Letter to the Editor Re: Gianluca Giannarini, Thomas M. Kessler, Frédéric D. Birkhäuser, George N. Thalmann, Urs E. Studer. Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit? Eur Urol 2011;60:955–60
15 December 2011
We were surprised to read the letter written by Chung et al. about our recent article published in the Platinum Journal reporting on our long-term experience with antegrade bacillus Calmette-Guérin (B...
|
Gianluca Giannarini,
Urs E. Studer
|
e22
|
|
| Congress Calendar |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Congress Calendar
|
|
632-637
|
|
